BILL vs TERN · rev $1.46B vs $6.12B cap
Bill Com Holdings Inc (BILL) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Bill Com Holdings Inc (BILL) is a software - application company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported BILL revenue for 2025-06-30 was $1.46B. Net income was $23.8M. Revenue was up 13.4% from 2024-06-30 to 2025-06-30. BILL currently screens at market cap $4.78B.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
BILL currently screens at market cap $4.78B. TERN currently screens at market cap $6.12B.
Not investment advice. Open the BILL and TERN stock pages for the full models.
Not investment advice.